Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan

OBJECTIVES: The aim of this study was to obtain real-world clinical data on the safety and efficacy of ranibizumab treatment for myopic choroidal neovascularization (CNV) due to pathologic myopia. METHODS: This was a prospective, observational, post-marketing surveillance study in ranibizumab-naive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno-Matsui, Kyoko, Suzaki, Makoto, Teshima, Rie, Okami, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292850/
https://www.ncbi.nlm.nih.gov/pubmed/30158574
http://dx.doi.org/10.1038/s41433-018-0192-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292850/
https://www.ncbi.nlm.nih.gov/pubmed/30158574
http://dx.doi.org/10.1038/s41433-018-0192-2

Ejemplares similares